Skip to content

Income Tax at other companies

Eli Lilly logo
Eli LillyLLY
$1.45B+109%
AbbVie logo
AbbVieABBV
$342M-8.1%
Xencor logo
XencorXNCR
$280K-23.7%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$6.37M+13.5%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$40K-9.1%
Absci Corporation logo
Absci CorporationABSI
$18K+550%

Other financials

Income statement

See full
Revenue$59.0K-69.3%
Gross profit$963.0K+8,855%
Operating income-$20.9M-42.5%
Net income-$19.6M-49.3%
EPS (diluted)-$0.98+21.6%

Balance sheet

See full
Cash & equivalents$25.3M-79.8%
Total debt$328.0K-59.1%
Total equity$68.3M-44.3%
Total assets$99.9M-27.9%

Cash flow

See full
Operating cash flow-$17.7M-87.1%
CapEx-
Free cash flow-$15.0M-444%

Valuation

See full
Market cap$954.59M+1,800%
Enterprise value$929.6M-1,353%
P/S1,909.2×+1,868×

Profitability

See full
Gross margin182%+176pp
Operating margin-15,536.1%-17,275pp
Net margin-7,965.8%-10,750pp
FCF margin-11,123.8%-13,374pp

Returns & leverage

See full
Return on equity-88.8%
Debt / equity0.0×
Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avalo Therapeutics's income tax?
Avalo Therapeutics (AVTX) reported income tax of $12K in Q1 2026.
How has Avalo Therapeutics's income tax changed year-over-year?
Avalo Therapeutics's income tax increased by 50.0% year-over-year, from $8K to $12K.
What is the long-term trend for Avalo Therapeutics's income tax?
Over 3 years (2021 to 2025), Avalo Therapeutics's income tax has grown at a -5.6% compound annual growth rate (CAGR), from -$196K to $165K.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.